Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival

<i>Mycobacterium bovis</i> Bacillus Calmette–Guérin (<i>M. bovis</i> BCG) was generated over a century ago for protection against <i>Mycobacterium tuberculosis</i> (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pel...

Full description

Bibliographic Details
Main Authors: Jordan Pascoe, Charlotte L. Hendon-Dunn, Colin P.D. Birch, Gareth A. Williams, Mark A. Chambers, Joanna Bacon
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/9/900
_version_ 1797552983975657472
author Jordan Pascoe
Charlotte L. Hendon-Dunn
Colin P.D. Birch
Gareth A. Williams
Mark A. Chambers
Joanna Bacon
author_facet Jordan Pascoe
Charlotte L. Hendon-Dunn
Colin P.D. Birch
Gareth A. Williams
Mark A. Chambers
Joanna Bacon
author_sort Jordan Pascoe
collection DOAJ
description <i>Mycobacterium bovis</i> Bacillus Calmette–Guérin (<i>M. bovis</i> BCG) was generated over a century ago for protection against <i>Mycobacterium tuberculosis</i> (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pellicle growth method, which is a complex and lengthy process that has been challenging to standardise. Fermentation for BCG vaccine production would reduce the complexity associated with pellicle growth and increase batch to batch reproducibility. This more standardised growth lends itself to quantification of the total number of bacilli in the BCG vaccine by alternative approaches, such as flow cytometry, which can also provide information about the metabolic status of the bacterial population. The aim of the work reported here was to determine which batch fermentation conditions and storage conditions give the most favourable outcomes in terms of the yield and stability of live <i>M. bovis</i> BCG Danish bacilli. We compared different media and assessed growth over time in culture, using total viable counts, total bacterial counts, and turbidity throughout culture. We applied fluorescent viability dyes and flow cytometry to measure real-time within-culture viability. Culture samples were stored in different cryoprotectants at different temperatures to assess the effect of these combined conditions on bacterial titres. Roisin’s minimal medium and Middlebrook 7H9 medium gave comparable, high titres in fermenters. Flow cytometry proved to be a useful tool for enumeration of total bacterial counts and in the assessment of within-culture cell viability and cell death. Of the cryoprotectants evaluated, 5% (<i>v/v</i>) DMSO showed the most significant positive effect on survival and reduced the negative effects of low temperature storage on <i>M. bovis</i> BCG Danish viability. In conclusion, we have shown a reproducible, more standardised approach for the production, evaluation, and storage of high titre, viable, BCG vaccine.
first_indexed 2024-03-10T16:08:57Z
format Article
id doaj.art-a8d2b9af0d31454a88074872f6c487d8
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T16:08:57Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-a8d2b9af0d31454a88074872f6c487d82023-11-20T14:37:38ZengMDPI AGPharmaceutics1999-49232020-09-0112990010.3390/pharmaceutics12090900Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage SurvivalJordan Pascoe0Charlotte L. Hendon-Dunn1Colin P.D. Birch2Gareth A. Williams3Mark A. Chambers4Joanna Bacon5TB Research Group, Public Health England, National Infection Service, Porton Down, Salisbury, Wiltshire SP4 0JG, UKTB Research Group, Public Health England, National Infection Service, Porton Down, Salisbury, Wiltshire SP4 0JG, UKDepartment of Epidemiological Sciences, Animal and Plant Health Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UKDepartment of Bacteriology, Animal and Plant Health Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UKDepartment of Bacteriology, Animal and Plant Health Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UKTB Research Group, Public Health England, National Infection Service, Porton Down, Salisbury, Wiltshire SP4 0JG, UK<i>Mycobacterium bovis</i> Bacillus Calmette–Guérin (<i>M. bovis</i> BCG) was generated over a century ago for protection against <i>Mycobacterium tuberculosis</i> (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pellicle growth method, which is a complex and lengthy process that has been challenging to standardise. Fermentation for BCG vaccine production would reduce the complexity associated with pellicle growth and increase batch to batch reproducibility. This more standardised growth lends itself to quantification of the total number of bacilli in the BCG vaccine by alternative approaches, such as flow cytometry, which can also provide information about the metabolic status of the bacterial population. The aim of the work reported here was to determine which batch fermentation conditions and storage conditions give the most favourable outcomes in terms of the yield and stability of live <i>M. bovis</i> BCG Danish bacilli. We compared different media and assessed growth over time in culture, using total viable counts, total bacterial counts, and turbidity throughout culture. We applied fluorescent viability dyes and flow cytometry to measure real-time within-culture viability. Culture samples were stored in different cryoprotectants at different temperatures to assess the effect of these combined conditions on bacterial titres. Roisin’s minimal medium and Middlebrook 7H9 medium gave comparable, high titres in fermenters. Flow cytometry proved to be a useful tool for enumeration of total bacterial counts and in the assessment of within-culture cell viability and cell death. Of the cryoprotectants evaluated, 5% (<i>v/v</i>) DMSO showed the most significant positive effect on survival and reduced the negative effects of low temperature storage on <i>M. bovis</i> BCG Danish viability. In conclusion, we have shown a reproducible, more standardised approach for the production, evaluation, and storage of high titre, viable, BCG vaccine.https://www.mdpi.com/1999-4923/12/9/900BCGfermentationflow cytometrycalcein violetsytox greencryoprotectant
spellingShingle Jordan Pascoe
Charlotte L. Hendon-Dunn
Colin P.D. Birch
Gareth A. Williams
Mark A. Chambers
Joanna Bacon
Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
Pharmaceutics
BCG
fermentation
flow cytometry
calcein violet
sytox green
cryoprotectant
title Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
title_full Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
title_fullStr Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
title_full_unstemmed Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
title_short Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
title_sort optimisation of i mycobacterium bovis i bcg fermentation and storage survival
topic BCG
fermentation
flow cytometry
calcein violet
sytox green
cryoprotectant
url https://www.mdpi.com/1999-4923/12/9/900
work_keys_str_mv AT jordanpascoe optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival
AT charlottelhendondunn optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival
AT colinpdbirch optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival
AT garethawilliams optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival
AT markachambers optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival
AT joannabacon optimisationofimycobacteriumbovisibcgfermentationandstoragesurvival